Mirum Pharmaceuticals, Inc. stock rating and score history
All changes in ratings, performance and outlook tracked over time.
Mirum Pharmaceuticals, Inc. stock price, chart patterns and momentum
Recent price movements, trend behaviour and momentum signals based on real-time market data.
What does Mirum Pharmaceuticals, Inc. do? Business model and key facts
Get the full picture of Mirum Pharmaceuticals, Inc.: what it builds, where it operates, and how it makes money.
Sector: Healthcare
Industry: Biotechnology
Employees (FY): 433
Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing groundbreaking therapies for serious rare and orphan conditions. Its lead experimental drug, LIVMARLI, an oral treatment, is currently undergoing trials for progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome, and biliary atresia. Furthermore, the company is advancing Volixibat to address intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Founded in 2018, Mirum Pharmaceuticals, Inc. operates from its headquarters in Foster City, California.
Stocks related to Mirum Pharmaceuticals, Inc.
Selected based on industry alignment and relative market positioning.
Events and news impacting Mirum Pharmaceuticals, Inc. stock
Earnings, coporate decisions and industry developments that can affect the share price.
Mirum Pharmaceuticals, Inc. fundamentals and technical analysis
Financial fundamentals and technicals signals combined to access stability, momentum and market direction.
